Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
ANNUAL INCOME RANGE
BANK MODIFICATION
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Company News
Remus Pharmaceuticals Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value(
)
78788
INE0O5T01011
139.278683
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
REMUS
70.12
1178.28
EPS(TTM)
Face Value(
)
Div & Yield %:
28.52
10
0
Back
Bliss GVS Pharma Ltd
Wanbury consolidated net profit declines 88.12% in the December 2024 quarter
Feb 13,2025
Net profit of Wanbury declined 88.12% to Rs 1.22 crore in the quarter ended December 2024 as against Rs 10.27 crore during the previous quarter ended December 2023. Sales declined 8.28% to Rs 133.45 crore in the quarter ended December 2024 as against Rs 145.50 crore during the previous quarter ended December 2023.
Particulars
Quarter Ended
Dec. 2024
Dec. 2023
% Var.
Sales
133.45
145.50
-8
OPM %
10.45
14.54
-
PBDT
4.62
13.58
-66
PBT
1.29
10.26
-87
NP
1.22
10.27
-88